|
|||
| |||||||||||||||||||||||||||||||
and interleukin-2, -4, and -53,4,5,6,7. Most patients also have deficient production of a B-cell differentiation factor, a 34-kd protein that has been purified and lacks interleukin-2, -4, -6, and -10 activity8. We and others hypothesized that the B cells in this disease may be defective because of a lack of essential cytokines9,10,11,12. Because Case Report
Methods
Protocol for PEG-Conjugated Interleukin-2
Lymphocyte Populations and Proliferation
Assays for Interleukin-2, Interleukin-6, and B-Cell Differentiation Factor
In Vitro Immunoglobulin Production
Serum Immunoglobulins and Antibody Production
Results
Lymphocyte Proliferation
Production of Interleukin-2 and Interleukin-6
B-Cell Differentiation Factor
Serum Immunoglobulins and Antibody Production
Clinical Effect
Discussion
Source Information
From the Division of Clinical Immunology, Department of Medicine, Mount Sinai Medical Center, 1 Gustave Levy Pl., New York, NY 10029, where reprint requests should be addressed to Dr. Cunningham-Rundles.
References
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |